MLICM
TNDM icon

Metropolitan Life Insurance Company (MetLife)’s Tandem Diabetes Care TNDM Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-14,046
Closed -$2.11M – 2660
2021
Q4 		$2.11M Sell
14,046
-127
-0.9% -$17.1K 0.03% 493
2021
Q3 		$1.69M Buy
14,173
+10,126
+250% +$1.12M 0.02% 596
2021
Q2 		$394K Sell
4,047
-5
-0.1% -$446 0.01% 1682
2021
Q1 		$358K Sell
4,052
-171
-4% -$15.9K 0.01% 1625
2020
Q4 		$404K Buy
4,223
+4
+0.1% +$412 0.01% 1497
2020
Q3 		$479K Sell
4,219
-50
-1% -$5.25K 0.01% 1246
2020
Q2 		$422K Sell
4,269
-12,691
-75% -$1.01M 0.01% 1340
2020
Q1 		$1.09M Sell
16,960
-740
-4% -$51.8K 0.02% 636
2019
Q4 		$1.06M Sell
17,700
-267
-1% -$16.5K 0.02% 868
2019
Q3 		$1.06M Buy
17,967
+1,204
+7% +$76.9K 0.02% 825
2019
Q2 		$1.08M Buy
16,763
+308
+2% +$19.9K 0.02% 848
2019
Q1 		$1.04M Sell
16,455
-434
-3% -$22.8K 0.02% 856
2018
Q4 		$641K Buy
16,889
+442
+3% +$15.6K 0.01% 1059
2018
Q3 		$705K Buy
+16,447
New +$574K 0.01% 1134
2016
Q1 		– Sell
-1,408
Closed -$166K – 2524
2015
Q4 		$166K Buy
1,408
+33
+2% +$3.27K ﹤0.01% 2377
2015
Q3 		$121K Buy
+1,375
New +$160K ﹤0.01% 2550
2014
Q2 		– Sell
-937
Closed -$207K – 2812
2014
Q1 		$207K Sell
937
-219
-19% -$55.8K ﹤0.01% 2438
2013
Q4 		$298K Buy
+1,156
New +$264K ﹤0.01% 2187

Other funds holding TNDM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s TNDM Position: Q1 2022 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Tandem Diabetes Care (TNDM) in Q1 2022, closing a stake of 14,046 shares — an estimated $2.11M sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in TNDM in Q4 2013 and held it in 18 quarters. The position peaked at $2.11M in Q4 2021. 379 funds tracked by Wall St. Rank hold TNDM as of Q1 2022.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Tandem Diabetes Care position as of Q1 2022 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 14,046 Tandem Diabetes Care shares in Q1 2022, an estimated $2.11M.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Tandem Diabetes Care in Q4 2013 and held it in 18 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Tandem Diabetes Care position peaked at $2.11M in Q4 2021.
  • 379 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2022.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2022, filed 12 May 2022.